Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amgen

298.81
+3.001.01%
Post-market: 298.810.00000.00%19:54 EDT
Volume:1.96M
Turnover:582.45M
Market Cap:160.87B
PE:24.43
High:299.37
Open:295.24
Low:293.14
Close:295.81
52wk High:335.88
52wk Low:253.30
Shares:538.36M
Float Shares:536.99M
Volume Ratio:0.92
T/O Rate:0.36%
Dividend:9.26
Dividend Rate:3.10%
EPS(TTM):12.23
EPS(LYR):7.62
ROE:99.14%
ROA:7.51%
PB:21.66
PE(LYR):39.23

Loading ...

US Equity Indexes Rise in Midday Trading

MT Newswires Live
·
Sep 27

Top Midday Stories: Amgen to Invest $650 Million to Expand US Manufacturing; Trump Signs TikTok Deal Order

MT Newswires Live
·
Sep 26

Amgen Is Maintained at Underperform by B of A Securities

Dow Jones
·
Sep 26

FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms

Reuters
·
Sep 26

Amgen to Invest $650M in U.S. Production Expansion as Trump Hikes Tariffs

Dow Jones
·
Sep 26

Amgen to Invest $650 Million in Expanding US Manufacturing Network

MT Newswires Live
·
Sep 26

Amgen Announces $650 Million Expansion of U.S. Manufacturing, Creating Nearly 750 New Jobs

Reuters
·
Sep 26

Amgen Announces $650M Expansion of U.S. Manufacturing, Creating Hundreds of New Jobs

THOMSON REUTERS
·
Sep 26

BRIEF-Amgen Announces More Than $650 Million Expansion Of Its Puerto Rico Manufacturing Facility

Reuters
·
Sep 26

Amgen: Expansion Expected to Create Nearly 750 Jobs

THOMSON REUTERS
·
Sep 26

Amgen Announces More Than $650 Mln Expansion of Its Puerto Rico Manufacturing Facility

THOMSON REUTERS
·
Sep 26

BUZZ-US pharma stocks mostly firm after Trump tariffs

Reuters
·
Sep 26

Dow Down 311 Points On Losses For Shares Of Nike, Amgen

Dow Jones
·
Sep 26

Dow's 119-Point Drop Led By Losses In Amgen, Apple Shares

Dow Jones
·
Sep 24

Amgen (AMGN) Receives a Hold from Citi

TIPRANKS
·
Sep 24

Citigroup Adjusts Price Target on Amgen to $315 From $310, Maintains Neutral Rating

MT Newswires Live
·
Sep 24

AstraZeneca and Amgen's Tezspire Recommended for EU Approval for Chronic Rhinosinusitis with Nasal Polyps Following Successful Phase III Trial Results

Reuters
·
Sep 23

Amgen call buyer realizes 206% same-day gains

TIPRANKS
·
Sep 22

AstraZeneca, Amgen’s Tezspire recommended for approval in EU

TIPRANKS
·
Sep 22

Amgen Inc. Stock Rallies 3.5%, Outperforms Peers

Dow Jones
·
Sep 20